Imaging and Physiologic Evaluation of Coronary Artery Disease

NCT ID: NCT05124249

Last Updated: 2025-02-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-11-01

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the long-term clinical outcomes and prognostic factors in patients with coronary artery disease (CAD) undergoing invasive coronary angiography (ICA), intravascular imaging, or invasive physiologic assessment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The traditional standard method for evaluating coronary artery disease (CAD) is invasive coronary angiography (ICA). ICA enables the assessment of anatomic severity of the epicardial artery and the severity of diameter stenosis can be closely associated with myocardial ischemia. However, there remains concern that anatomical severity is not always identical with functional significance. Actually, even the patients showed positive non-invasive tests including treadmill test, stress echocardiography, coronary computed tomography angiography, or nuclear imaging, less than half of the patients showed significant stenosis on ICA. Therefore, the investigators need further investigation to overcome the limitations of ICA.

In this regard, intravascular imaging, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is a useful tool for assessing the anatomical severity in more detail. Those imaging modalities produce cross-sectional images of CAD and imaging modalities are allowing to assess lesion characteristics, plaque morphology, treatment planning, and optimization of the implanted stent. Furthermore, imaging-guided percutaneous coronary intervention (PCI) has been shown favorable outcomes, compared with angiography only-guided PCI, especially in complex lesions. Meanwhile, there has been an ample body of evidence that invasive coronary physiology assessment, such as fractional flow reserve (FFR), also can be useful for assessing the functional significance. Therefore, the current guidelines have continuously recommended intracoronary imaging and invasive physiologic assessment for guiding the treatment of CAD.

The aim of the IP-CAD (Imaging and Physiologic Evaluation of Coronary Artery Disease: a Prospective Registry Study) is to evaluate the long-term clinical outcomes according to the imaging-guided or physiology-guided PCI in real-world practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischemic Heart Disease Atherosclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Invasive coronary angiography (ICA)

Patients who undergoing invasive coronary angiography with intravascular imaging or invasive physiologic assessment

Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment

Intervention Type DIAGNOSTIC_TEST

Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment

Percutaneous coronary intervention (PCI)

Patients who undergoing percutaneous coronary intervention with intravascular imaging or invasive physiologic assessment

Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment

Intervention Type DIAGNOSTIC_TEST

Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment

PCI

Intervention Type PROCEDURE

Patients who undergoing PCI

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment

Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment

Intervention Type DIAGNOSTIC_TEST

PCI

Patients who undergoing PCI

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject must be at least 18 years of age
* Subjects who suspected ischemic heart disease and underwent ICA.
* Subjects who were performed intravascular imaging or invasive physiologic assessment

Exclusion Criteria

* Subject with Age \<18 years
* Pregnant women
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chonnam National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Young Joon Hong

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Young Joon LeeHong, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Chonnam National University Medical School; Chonnam National University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chonnam National University Hospital

Gwangju, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Young Joon Hong, MD, PhD

Role: CONTACT

82-62-220-5778

Seung Hun Lee, MD, PhD

Role: CONTACT

82-62-220-4246

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Young Joon Hong, MD, PhD

Role: primary

82-62-220-5778

Seung Hun Lee, MD, PhD

Role: backup

82-62-220-4246

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CNUH-2021-314

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Perfusion CT Registry
NCT01696006 COMPLETED